Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)
Clinical trial NCT04706793 · COMPLETED
Trial details
- NCT number
- NCT04706793
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-25
- Primary completion
- 2022-08-03
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.